Share on Pinterest An experimental CRISPR-based gene editing treatment significantly improved vision outcomes in subjects with a rare eye disorder. Robert Nickelsberg/Getty Images Researchers from ...

A single dose of EDIT-101, a CRISPR-associated protein 9 (Cas9)-based gene-editing therapy, appears safe and improves vision and sensitivity to light in patients with retinal disease associated with ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A subretinal ...

Scientists have identified a gene responsible for some inherited retinal diseases (IRDs), which are a group of disorders that damage the eye's light-sensing retina and threatens vision. Though IRDs ...

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by working to bring to market three treatments for blindness-related diseases, two ...

Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular ...

Little Harvey Haines has been given a new lease of life. Born with a rare eye condition severely affecting his sight, he struggled to communicate with children his own age, shied away from ...

Parents, have you ever heard of the term horner syndrome? This is a rare disorder that can affect your child’s eyes. In some cases, this syndrome has even appeared since the child was born. Sometimes ...

A recent study finds that certain psychiatric disorders have considerable genetic overlap. But these genes aren’t the whole ...